Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.

Foreign investors struggle to keep up with India's rise



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>RPT-ANALYSIS-Foreign investors struggle to keep up with India's rise</title></head><body>

Repeats story from Thursday.

India surges toward leading position on EM benchmark

Mid and large stocks have highest PE ratio globally - LSEG

Funds shy of buying deepen underweight allocation

By Ankur Banerjee

SINGAPORE, Sept 5 (Reuters) -India's stock market rally is ramping up its index weighting and creating a dilemma for global fund managers: sit back and watch as their relative exposure shrinks while the market grows, or buy in at increasingly eye-watering prices.

Most find the latter uncomfortably risky and are seeking alternatives, some driving money into India's smaller companies, while others are looking elsewhere at other emerging markets.

The trend has been driven by years of strong earnings in India at the same time as China's markets have stumbled, upending their weightings in the MSCI Emerging Markets' Index .MSCIEF which serves as a benchmark for global EM funds.

India's MSCI EM weight has shot to 19%, up from just 8% four years ago and analysts at Nuvama Alternative & Quantitative Research expect it to top 22% by the end of this year. China's weighting over the same period has collapsed from 40% to 25%, data from MSCI shows.

"The convergence between India and China is causing problems for a lot of portfolio managers because if you had a global mandate or a pan-Asia mandate, you probably were at best equal weight India and probably underweight," said Vikas Pershad, portfolio manager for Asian equities at M&G Investments.

"And that underweight is growing."

Part of the reason for the long-term underweight has been that many investors preferred China's cheaper and dynamic market, while entry and exit costs for funds can be high in India.

Managers would need to buy Indian companies at a rapid clip to keep up with their increasing presence in indexes, which with an average 12-month price-to-earnings ratio of 24 times for big and middle-sized firms are the most expensive in major markets, according to LSEG data.

Many are choosing not to do so, leaving India the biggest underweight allocation among emerging market funds, according to HSBC and Copley Fund Research.

Valuations for Chinese blue chips .CSI300, by contrast, are far lower with the same price-to-earnings measure at 17 and at 15 for big Malaysian stocks .KLSE.

For Gary Tan, portfolio manager at Allspring Global Investments, and his clients, valuations are the sticking point.

"We are optimistic on the long-term story, but really cautious on where valuations are," said Tan, who has been underweight India for the last couple of years.


NO SECRET

Valuations have long been relatively high in India and no barrier to outperformance. Now, however, some investors are becoming wary of the risk-reward balance.

India's Nifty 50 index .NSEI has risen 145% and the S&P BSE Sensex .BSESN has surged 136% since mid-2020, while the S&P 500 .SPX in the same period has gained 78% and China's blue-chip index .CSI300 has slid 22%.

Yet while foreigners have been consistent buyers of Indian stocks this year and in 2023, the flow and sentiment is beginning to shift.

ICICI Securities data shows foreign buying over the first half of this year has been much higher in small to mid size firms than in large caps and in August, exchange data showed foreigners turned sellers of $662 million in shares.

Foreign investors account for roughly 16% of total Indian stocks holding, according to ICICI Securities, the lowest in a decade.

To be sure, there are plenty of bulls and money that isn't benchmarked to emerging markets' indexes that is flowing in.

Howie Schwab, portfolio manager for emerging markets growth at Driehaus Capital, said there's an increased interest from global investors in India, not just from those with emerging markets mandates.

Vivian Lin Thurston, portfolio manager for William Blair's emerging markets growth strategy, says valuation alone is not necessarily reason enough to look elsewhere.

"Do I have another attractive opportunity set to put money in if I take down India, the answer is not many at present, and this is a factor I'm struggling with, or grappling with," she said.

However flows into Malaysia and Indonesia, where markets are on a tear, point to investors looking further afield, for now.

"India's economic growth story is not a secret," said James Cook, investment director for global emerging markets at U.S. fund manager Federated Hermes, who is underweight India and waiting for prices to fall before buying any further.

"When you have such a consensus, and the outlook appears to be benign, investors can fall into a trap, blind to any potential pitfalls, such as paying too high a price to participate."



Reporting by Ankur Banerjee in Singapore, additional reporting by Gaurav Dogra and Bharath Rajeswaran in Bengaluru; editing by Tom Westbrook and Shri Navaratnam

</body></html>

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.